Search for: "Apotex Inc."
Results 261 - 280
of 674
Sort by Relevance
|
Sort by Date
10 Jun 2014, 5:25 pm
ApotexApotex Inc., Apotex Corp., Sandoz, Inc., Hit-TechPharmacal Co., Inc., Actavis, Inc., Watson Laboratories,Inc., and Watson Pharma, Inc. [read post]
9 Jun 2014, 4:00 am
On Tuesday 10 June 2014, the Court will hear the appeal of Les Laboratoires Servier & Anor v Apotex Inc & Ors in Court 2 from 10.00 am. [read post]
16 May 2014, 4:42 am
Apotex, Inc., 480 F.3d 1348, 1361 (Fed. [read post]
27 Apr 2014, 9:01 pm
• Defendants: Apotex, Inc.; Apotex Corp. [read post]
24 Apr 2014, 9:55 pm
• Defendants: Apotex Corp.; Apotex Inc. [read post]
23 Apr 2014, 7:44 am
Apotex, Inc., 633 F.3d1042, 1059–60 (Fed. [read post]
22 Apr 2014, 11:29 pm
Apotex, Inc., 550 F.3d 1075, 1082(Fed. [read post]
14 Apr 2014, 9:59 pm
Apotex Inc. that is a cautionary tale of patent lifecycle and the difficulties those seeking to extend patent protection face -- namely the blooming of prior art relating to an approved product. [read post]
13 Apr 2014, 10:00 pm
Apotex, Inc., the Federal Circuit affirmed the district court’s summary judgment that two Roche Boniva patents are invalid as obvious. [read post]
13 Apr 2014, 8:59 am
Apotex Inc. v. [read post]
12 Apr 2014, 6:39 am
Apotex, Inc., 480 F.3d 1348, 1364 (Fed. [read post]
11 Apr 2014, 11:29 am
Apotex Inc., No. 2013-1128, -1161, -1162, -1163, -1164 (April 11, 2014).IssueThe issue in this case is whether it would have been obvious at the time of invention to select a once monthly oral dosing regimen of ibandronate to treat osteoporosis and to set that dose at 150 mg [based on prior art references teaching a daily dosage amount].Hoffmann-La Roche, Inc. at *9 (text added).Holding[T]he prior art pointed to a monthly treatment of 150 mg of ibandronate. [read post]
10 Apr 2014, 5:17 pm
Apotex Corp., 439 F.3d 1312, 1320 (Fed. [read post]
8 Apr 2014, 9:55 am
Apotex, Inc., 480 F.3d1348, 1364 (Fed. [read post]
7 Apr 2014, 9:59 pm
The case involved patentee Senju Pharmaceutical's (joined by Kyorin Pharmaceutical Co. and Allergan, Inc.) suit against Apotex in response to a Paragraph IV certification against Senju's patented ocular antimicrobial agent containing the drug Gatifloxacin as claimed in U.S. [read post]
3 Apr 2014, 9:55 pm
• Defendants: Apotex Inc.; Apotex Corp. [read post]
1 Apr 2014, 7:17 pm
Apotex Inc., No. 2013-1027 (Fed. [read post]
19 Mar 2014, 9:00 am
Apotex relies on hundreds of prior art documents. [read post]
5 Mar 2014, 10:05 am
Cir. 2002), and Senmed, Inc. v. [read post]
29 Jan 2014, 9:12 pm
Apotex, Inc., 480 F.3d 1348, 1372 (Fed. [read post]
